BTC $78,496.23 -0.45%
ETH $2,473.55 +0.64%
BNB $700.05 +0.38%
XRP $1.38 -5.39%
SOL $96.90 -0.81%
TRX $0.3357 -0.68%
DOGE $0.0850 -3.18%
ADA $0.2061 -3.60%
BCH $262.22 -1.49%
LINK $11.28 -1.39%
HYPE $81.44 +0.36%
AAVE $123.55 -2.97%
SUI $0.7392 -4.06%
XLM $0.1797 -4.36%
ZEC $784.61 -0.04%
BTC $78,496.23 -0.45%
ETH $2,473.55 +0.64%
BNB $700.05 +0.38%
XRP $1.38 -5.39%
SOL $96.90 -0.81%
TRX $0.3357 -0.68%
DOGE $0.0850 -3.18%
ADA $0.2061 -3.60%
BCH $262.22 -1.49%
LINK $11.28 -1.39%
HYPE $81.44 +0.36%
AAVE $123.55 -2.97%
SUI $0.7392 -4.06%
XLM $0.1797 -4.36%
ZEC $784.61 -0.04%

以太坊财库公司 Propanc Biopharma 与 Hexstone Capital 达成最高 1 亿美元战略融资协议

2025-10-16 09:12:45

ChainCatcher 消息,采用以太坊财库战略的生物制药公司 Propanc Biopharma 宣布与家族办公室 Hexstone Capital 达成最高 1 亿美元的战略融资协议。Propanc CEO James Nathanielsz 表示,此次融资将加速公司临床管线开发,并计划在未来 12 个月内将数字资产库价值增长至 1 亿美元或以上。

Hexstone Capital 此前已投资多家拥有数字资产库的公司,涉及 BTC、ETH、SOL、DOGE 等多种数字资产。此前消息,九月初 Propanc Biopharma 宣布计划收购 1 亿美元以太坊。

app_icon
ChainCatcher Building the Web3 world with innovations.